This research develops orally administered nanoparticles that target the lymphatic system to treat lupus and osteoporosis simultaneously. By delivering drugs directly to affected tissues while avoiding the bloodstream, the approach reduces toxicity, suppresses inflammatory and bone-damaging genes, and offers a more effective strategy for treating these complex chronic diseases.

This research investigates how Type 1 diabetes affects bone development during childhood and adolescence. Using high-resolution bone imaging and blood glucose data, the study explores whether blood sugar levels, variability, and disease duration influence bone health. Early findings suggest that diagnosis closer to puberty may be associated with lower bone density.

This research adapts fracture prevention guidelines for older adults receiving home care in Canada. By addressing unique risk factors through nutrition, exercise, and medication management, the study aims to reduce falls and fractures, helping individuals age safely at home and maintain independence for longer.